CLEVELAND, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chairman and CEO Michael B. Petras, Jr. will present at the 43rdAnnual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025 at 11:15 a.m. Eastern Time. Mr. Petras, Jon Lyons, Senior Vice President and CFO, and Jason Peterson, Vice President, Investor Relations and Treasurer, will participate in meetings with investors during the conference.
A live webcast of Mr. Petras’ presentation and accompanying materials may be accessed via the Investor Relations section of the Company’s website atPresentation & Events | Sotera Health. A replay of the webcast will be available within 48 hours following the conclusion of the conference and archived on the Company's website.
About Sotera Health:Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website atInvestor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found atEthylene Oxide | Sotera Health.
INVESTOR RELATIONS CONTACTS:Jason PetersonVice President, Investor Relations & TreasurerIR@soterahealth.com
MEDIA CONTACT:Kristin GibbsChief Marketing Officerkgibbs@soterahealth.com
Source: Sotera Health Company
